Polomar Health Services, Inc.
PMHS
$0.39
-$0.01-2.50%
| Weiss Ratings | PMHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | PMHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | PMHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | PMHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -2.50% | |||
| 60-Day Total Return | -2.50% | |||
| 90-Day Total Return | 52.64% | |||
| Year to Date Total Return | 454.77% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -74.00% | |||
| 52-Week Low % Change | 454.77% | |||
| Price | PMHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.50 | |||
| 52-Week Low Price | $0.07 | |||
| 52-Week Low Price (Date) | Dec 30, 2024 | |||
| 52-Week High Price (Date) | Oct 31, 2024 | |||
| Valuation | PMHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 10.79M | |||
| Enterprise Value | 11.66M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | 58.06% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1,300.00 | |||
| Price/Book (Q) | 1.16 | |||
| Enterprise Value/Revenue (TTM) | 1,189.93 | |||
| Price | $0.39 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -44.99 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | PMHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 27.66M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PMHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 212-245-3413 | |||
| Address | 10940 Wilshire Boulevard Los Angeles, CA 90024 | |||
| Website | polomarsp.com | |||
| Country | United States | |||
| Year Founded | 2023 | |||
| Profitability | PMHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | PMHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | PMHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | -54.42% | |||
| Earnings Growth (Q YOY) | -57.55% | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | -58.06% | |||
| Balance Sheet | PMHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 16.20K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 156.10K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 9.32M | |||
| Current Ratio (Q) | 0.164 | |||
| Book Value Per Share (Q) | $0.34 | |||
| Total Assets (Q) | 10.30M | |||
| Total Current Liabilities (Q) | 953.80K | |||
| Total Debt (Q) | 891.10K | |||
| Total Liabilities (Q) | 977.40K | |||
| Total Common Equity (Q) | 9.32M | |||
| Cash Flow | PMHS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
